-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 GoPvvEfjaYReyE+Ke9Mfz1CPHpE+c///NMQExanRS7cTWF1vOFhQX25Zt1oJgAKX
 CjvAAzZqegwc7cXvC0CKOQ==

<SEC-DOCUMENT>0001362310-08-002785.txt : 20080514
<SEC-HEADER>0001362310-08-002785.hdr.sgml : 20080514
<ACCEPTANCE-DATETIME>20080514162803
ACCESSION NUMBER:		0001362310-08-002785
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20080514
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20080514
DATE AS OF CHANGE:		20080514

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				841097796
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30489
		FILM NUMBER:		08832170

	BUSINESS ADDRESS:	
		STREET 1:		6400 SOUTH FIDDLER
		STREET 2:		SUITE 1750
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80111
		BUSINESS PHONE:		720-488-1711

	MAIL ADDRESS:	
		STREET 1:		6400 SOUTH FIDDLER
		STREET 2:		SUITE 1750
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80111

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>c73415e8vk.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>Filed by Bowne Pure Compliance</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">
<DIV style="font-size: 10pt">
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>

<P style="font-size: 14pt" align="center"><B>UNITED STATES<BR>
SECURITIES AND
EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P style="font-size: 18pt" align="center"><B>FORM 8-K</B>

<P style="font-size: 12pt" align="center"><B>CURRENT REPORT<BR>
Pursuant to
Section 13 OR 15(d) of The Securities Exchange Act of 1934</B>

<P style="font-size: 10pt" align="center"><B>Date of Report (Date of earliest
event reported): May 14, 2008</B>


<P style="font-size: 24pt" align="center"><B>Lifevantage
Corporation<BR>
</B><FONT style="font-size: 10pt">(Exact name of registrant as
specified in its charter) </FONT>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="32%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="33%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="32%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>Colorado</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>000-30489</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>90-0224471</B></TD>
 </TR>
 <TR valign="top">
  <TD>(State or other Jurisdiction of Incorporation)</TD>
  <TD>&nbsp;</TD>
  <TD>(Commission File Number)</TD>
  <TD>&nbsp;</TD>
  <TD>(IRS Employer Identification No.)</TD>
 </TR>

</TABLE>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="49%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="49%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>6400 South Fiddler&#8217;s
Green Circle, Suite 1970,<br>Greenwood Village, CO <BR>
</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>80111</B></TD>
 </TR>
 <TR valign="top">
  <TD>(Address of Principal Executive Offices)</TD>
  <TD>&nbsp;</TD>
  <TD>(Zip Code)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="center">Registrant&#8217;s telephone number,
including area code: <B>(720) 488-1711</B>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="30%" border="0">

 <TR>
  <TD width="100%">&nbsp;</TD>
 </TR>
 <TR>
  <TD style="border-bottom: #000000 1px solid" nowrap><B>&nbsp;</B></TD>
 </TR>
 <TR>
  <TD nowrap>(Former name or former address if changed since last report.)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="left">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:

<P style="font-size: 10pt" align="left"><FONT face="Wingdings">o</FONT> Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)<BR>
<BR>
<FONT face="Wingdings">o</FONT> Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>



<DIV
style="margin-top: 10pt; font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
</DIV>

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;2.02 Results of Operations and Financial Conditions</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">On May&nbsp;14, 2008, Lifevantage Corporation issued a press release entitled, &#147;Lifevantage
Corporation Announces 3Q FY 2008 Financial and Operating Results&#148;. The press release is attached
as Exhibit&nbsp;99.1 hereto, which is furnished under Item&nbsp;2.02 of this report and shall not be deemed
to be &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the
&#147;Exchange Act&#148;) or otherwise subject to the liabilities of that section, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of 1933, as amended (the
&#147;Securities Act&#148;) or the Exchange Act, regardless of any general incorporation language in such
filing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">On May&nbsp;14, 2008, Lifevantage Corporation issued a press release entitled, &#147;Lifevantage
Corporation Schedules 3rd Quarter FY 2008 Conference Call&#148;. The press release is attached as
Exhibit&nbsp;99.2 hereto, which is furnished under Item&nbsp;2.02 of this report and shall not be deemed to
be &#147;filed&#148; for purposes of Section&nbsp;18 of the Exchange Act or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference in any filing under the
Securities Act or the Exchange Act, regardless of any general incorporation language in such
filing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;7.01 Regulation&nbsp;FD Disclosure</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">On May&nbsp;14, 2008, Lifevantage Corporation issued a press release entitled, &#147;Lifevantage
Corporation Announces 3Q FY 2008 Financial and Operating Results&#148;. The press release is attached
as Exhibit&nbsp;99.1 hereto, which is furnished under Item&nbsp;7.01 of this report and shall not be deemed
to be &#147;filed&#148; for purposes of Section&nbsp;18 of the Exchange Act or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference in any filing under
the Securities Act or the Exchange Act, regardless of any general incorporation language in such
filing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">On May&nbsp;14, 2008, Lifevantage Corporation issued a press release entitled, &#147;Lifevantage
Corporation Schedules 3rd Quarter FY 2008 Conference Call&#148;. The press release is attached as
Exhibit&nbsp;99.2 hereto, which is furnished under Item&nbsp;7.01 of this report and shall not be deemed to
be &#147;filed&#148; for purposes of Section&nbsp;18 of the Exchange Act or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference in any filing under the
Securities Act or the Exchange Act, regardless of any general incorporation language in such
filing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;9.01 Exhibits</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">99.1 Press release, dated May&nbsp;14, 2008, entitled, &#147;Lifevantage Corporation Announces 3Q FY
2008 Financial and Operating Results&#148;.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">99.2 Press release, dated May&nbsp;14, 2008, entitled, &#147;Lifevantage Corporation Schedules 3rd
Quarter FY 2008 Conference Call&#148;.
</DIV>


<P style="font-size: 10pt; text-indent: 4%" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="center"><B>SIGNATURES</B>

<P style="font-size: 10pt" align="left">Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned thereunto duly authorized.

<P style="font-size: 10pt" align="left">Date: May&nbsp;14, 2008

<P style="font-size: 10pt; margin-left: 45%" align="left">LIFEVANTAGE
CORPORATION

<P style="font-size: 10pt; margin-left: 45%" align="left">By: <U>/s/ Bradford
K.
Amman&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><BR>
Bradford
K. Amman<BR>
Chief Financial Officer<BR>


<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="center"><B>EXHIBIT INDEX</B>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%"
border="0">
<!-- Begin Table Head -->

 <TR valign="bottom">
  <TD width="10%">&nbsp;</TD>
  <TD width="5%">&nbsp;</TD>
  <TD width="85%">&nbsp;</TD>
 </TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
 <TR valign="bottom">
  <TD valign="bottom">
<DIV style="margin-left: 0px; text-indent: 0px"><B>Exhibit No.</B>&nbsp;</DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left"><B>Description</B></TD>
 </TR>
 <TR style="font-size: 1px">
  <TD style="border-top: #000000 1px solid" valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">&nbsp;</DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD style="border-top: #000000 1px solid" valign="top"
align="left">&nbsp;</TD>
 </TR>
<!-- End Table Body -->

</TABLE>
</DIV>

<P>
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%"
border="0">

 <TR
style="font-size: 10pt; background: none transparent scroll repeat 0% 0%; color: #000000"
valign="top">
  <TD nowrap align="left" width="10%">99.1</TD>
  <TD width="5%">&nbsp;</TD>
  <TD>Press release, dated May&nbsp;14, 2008, entitled, &#8220;Lifevantage
Corporation Announces 3Q FY 2008 Financial and Operating Results&#8221;.</TD>
 </TR>

 <TR
style="font-size: 10pt; background: none transparent scroll repeat 0% 0%; color: #000000"
valign="top">
  <TD nowrap align="left" width="10%">&nbsp;</TD>
  <TD width="5%">&nbsp;</TD>
  <TD>&nbsp;</TD>
 </TR>

 <TR
style="font-size: 10pt; background: none transparent scroll repeat 0% 0%; color: #000000"
valign="top">
  <TD nowrap align="left" width="10%">99.2</TD>
  <TD width="5%">&nbsp;</TD>
  <TD>Press release, dated May&nbsp;14, 2008, entitled, &#147;Lifevantage Corporation Schedules 3rd
Quarter FY 2008 Conference Call&#148;.</TD>
 </TR>
</TABLE>



<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">4
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>c73415exv99w1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
<TITLE>Filed by Bowne Pure Compliance</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="right" style="font-size: 10pt; margin-top: 10pt"><B>Exhibit&nbsp;99.1</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><IMG src="c73415p7341501.jpg" alt="(LIFEVANTAGE LOGO)">
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="47%"></TD>
    <TD width="5%"></TD>
    <TD width="47%"></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top"><B>FOR IMMEDIATE RELEASE</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top"><B>NEWS</B></TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="47%"></TD>
    <TD width="5%"></TD>
    <TD width="47%"></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">May&nbsp;14, 2008
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">OTCBB: LFVN</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>LIFEVANTAGE CORPORATION ANNOUNCES<BR>
3Q FY 2008 FINANCIAL AND OPERATING RESULTS</B>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">GREENWOOD VILLAGE, Colorado &#151; LifeVantage Corporation (OTCBB: LFVN), maker of
Protandim<SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP>, today announced results for its third quarter ended March&nbsp;31, 2008. For the
three month period ended March&nbsp;31, 2008, the Company recorded net revenues of $0.8&nbsp;million and a
loss of $(0.6) million, or $(0.03) per share. For the three month period ended March&nbsp;31, 2007, the
Company recorded net revenues of $1.0&nbsp;million and a loss of $(0.6) million, or $(0.03) per share.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">For the nine month period ended March&nbsp;31, 2008, the Company recorded net revenues of $2.4&nbsp;million
and a loss of $(1.3) million, or $(0.06) per share comparing to net revenues of $4.2&nbsp;million and a
loss of $(3.2) million, or $(0.14) per share for the nine month period ended March&nbsp;31, 2007.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">LifeVantage President and CEO, David W. Brown, commented, &#147;While net sales have been relatively
flat over the last three quarters, during the last three months we have succeeded in stabilizing
the downward sales trend the Company has experienced in recent years. We have strengthened our
management team with proven professionals, launched the Company&#146;s first nation-wide television
media test and significantly increased our Internet presence. We believe that we are now poised for
significant customer acquisition and sales growth.&#148;
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>About Protandim<SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP></B>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">Protandim<SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP> is a unique approach to fighting the effects of cell-damaging free radical molecules
which advance the aging process, including many of the diseases of aging. The patented dietary
supplement increases the body&#146;s natural antioxidant protection by inducing the cells of the body to
produce naturally occurring protective antioxidant enzymes, a process which is thousands of times
more effective than traditional vitamin-mineral supplements. Free radical damage occurs when a
person is subjected to environmental stresses and generally increases with age. Data from a
peer-reviewed scientific study in men and women, sponsored by LifeVantage, show that after 30&nbsp;days
of taking Protandim<SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP>, the level of circulating toxins produced by free radicals decreased an
average of 40&nbsp;percent. With continued use, the decrease was maintained at 120&nbsp;days. For more
information, please visit the Protandim<SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP> product web site at <U>www.protandim.com</U> or contact Jan
Strode at (619)&nbsp;890-4040.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>About LifeVantage Corporation</B>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">LifeVantage Corporation is a publicly traded (OTCBB:LFVN), science based, natural products company,
dedicated to helping people reach their health and wellness goals through science-based solutions
to oxidative stress. Founded in 2003 and based in Colorado, LifeVantage develops nutraceutical
products, including Protandim, that leverage the company&#146;s expertise and that are
intended to deliver significant health benefits to consumers. For more information, visit
<U>www.protandim.com</U> or contact Jan Strode at (619)&nbsp;890-4040.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><I>This press release contains forward-looking statements made pursuant to the safe harbor provisions
of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based
on the Company&#146;s current expectations and beliefs concerning future events affecting the Company
and involve known and unknown risks and uncertainties including the risk that sales of our product
may not continue at the levels discussed in this press release. These risks and uncertainties may
cause the Company&#146;s actual results or outcomes to be materially different from those anticipated
and discussed herein. These and other risk factors are discussed in greater detail in the Company&#146;s
Annual Report on </I><I>Form 10-KSB</I><I> for the year ended June&nbsp;30, 2007, and in other documents filed by the
Company from time to time with the Securities and Exchange Commission. The Company cautions
investors not to place undue reliance on the forward-looking statements contained in this press
release. All forward-looking statements are based on information currently available to the
Company, and the Company undertakes no obligation to revise or update these forward-looking
statements.</I>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B># # #</B>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>CONTACTS:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="48%">&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>LifeVantage Corporation</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Jan Strode, Investor Relations</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>Telephone: (619)&nbsp;890-4040</B></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Bradford Amman, CFO</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>Telephone: (720)&nbsp;488-1711</B></TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="center" style="font-size: 10pt; margin-top: 10pt">LIFEVANTAGE CORPORATION<BR>
CONDENSED CONSOLIDATED BALANCE SHEETS
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="66%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2">(Unaudited)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2">(Audited)</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">March 31, 2008</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">June 30, 2007</TD>
    <TD>&nbsp;</TD>
</TR>


<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ASSETS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Current assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Cash and cash equivalents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">187,229</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">160,760</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Marketable securities, available for sale</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,375,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Accounts receivable, net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">127,158</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">398,463</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Inventory</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">104,833</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27,834</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Deferred expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">73,204</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">117,807</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Deposit with manufacturer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">306,084</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">388,791</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Prepaid expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">112,229</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60,175</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Total current assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,285,737</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,153,830</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Long-term assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Property and equipment, net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">76,848</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">108,915</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Intangible assets, net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,281,653</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,311,110</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Deferred debt offering costs, net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">214,806</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Deposits</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">61,144</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">340,440</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">TOTAL ASSETS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">4,920,188</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">3,914,295</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">LIABILITIES AND STOCKHOLDERS&#146; EQUITY</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Current liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Accounts payable</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">252,807</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">148,699</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Accrued expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">379,134</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">230,811</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Deferred revenue</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">519,030</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">818,250</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Capital lease obligations, current portion</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,453</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,301</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Revolving line of credit and accrued interest</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">250,379</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Total current liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,402,803</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,200,061</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Long-term liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Capital lease obligations, net of current portion</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">846</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Convertible debt, net of discount</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">275,513</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Total liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,678,316</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,200,907</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Commitments and Contingencies</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Stockholders&#146; equity</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Common stock, par value $.001, 250,000,000 shares
authorized; 22,613,488 and 22,268,034 issued and
outstanding as of March&nbsp;31, 2008 and June&nbsp;30, 2007,
respectively</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22,613</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22,268</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Additional paid-in capital</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17,228,317</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15,395,037</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Accumulated (deficit)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(14,009,058</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(12,703,917</TD>
    <TD nowrap>)</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Total stockholders&#146; equity</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,241,872</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,713,388</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">TOTAL LIABILITIES AND STOCKHOLDERS&#146; EQUITY</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">4,920,188</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">3,914,295</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
        <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
        <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="center" style="font-size: 10pt; margin-top: 10pt">LIFEVANTAGE CORPORATION<BR>
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS<BR>
(Unaudited)
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="44%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6">For the three months ended</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6">For the nine months ended</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6" style="border-bottom: 1px solid #000000">March 31,</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6" style="border-bottom: 1px solid #000000">March 31,</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">2007</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">2008</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">2007</TD>
    <TD>&nbsp;</TD>
</TR>


<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Sales, net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">783,946</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">995,274</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">2,387,677</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">4,207,518</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cost of sales</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">174,890</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">213,529</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">538,212</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">838,244</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Gross profit</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">609,056</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">781,745</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,849,465</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,369,274</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Operating expenses:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Marketing and customer service</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">357,990</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">504,616</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,021,111</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,605,616</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">General and administrative</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">702,404</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">806,878</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,606,926</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,606,824</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Research and development</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25,045</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">57,318</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">243,934</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">195,654</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Depreciation and amortization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60,865</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16,622</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">159,750</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">76,636</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Loss on disposal of assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">95,654</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Total operating expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,146,304</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,385,434</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,031,721</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6,580,384</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Operating loss</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(537,248</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(603,689</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(1,182,256</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(3,211,110</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Other (expense)&nbsp;and income:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Interest (expense)/income</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(67,408</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15,403</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(122,885</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">46,110</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Other income/(expense)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,953</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(2,547</TD>
    <TD nowrap>)</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Net other (expense)&nbsp;income</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(67,408</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21,356</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(122,885</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43,563</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Net loss</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(604,656</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(582,333</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(1,305,141</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(3,167,547</TD>
    <TD nowrap>)</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Net loss per share, basic and diluted</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">($0.03</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">($0.03</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">($0.06</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">($0.14</TD>
    <TD nowrap>)</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Weighted average shares outstanding,
basic and fully diluted</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22,464,168</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22,118,034</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22,349,282</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22,118,034</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
        <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
        <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
        <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
        <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>c73415exv99w2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
<TITLE>Filed by Bowne Pure Compliance</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="right" style="font-size: 10pt; margin-top: 10pt"><B>Exhibit&nbsp;99.2</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><IMG src="c73415p7341501.jpg" alt="(LOGO)">
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="47%"></TD>
    <TD width="5%"></TD>
    <TD width="47%"></TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top"><B>&nbsp;</B></TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top"><B>FOR IMMEDIATE RELEASE</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top"><B>NEWS</B></TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">May&nbsp;14, 2008
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">OTCBB: LFVN</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>LIFEVANTAGE CORPORATION SCHEDULES 3RD QUARTER FY 2008<BR>
CONFERENCE CALL</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">GREENWOOD VILLAGE, Colorado &#151; LifeVantage Corporation (OTCBB: LFVN), maker of
Protandim<SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP>, will hold a conference call on May&nbsp;22, 2008 at 2:00 p.m. MT (4:00 p.m. ET)
to discuss its third quarter fiscal year 2008 financial and operating results and its national
television advertising campaign.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Interested parties may listen to the call by dialing 800-257-2182. A replay of the call also will
be available by telephone until May&nbsp;29, 2008 at 800-405-2236 passcode 11114490#.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>About Protandim</B><SUP style="font-size: 85%; vertical-align: text-top"><B><SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP> </B></SUP>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Protandim<SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP> is a unique approach to fighting the effects of cell-damaging free radical molecules
which advance the aging process, including many of the diseases of aging. The patented dietary
supplement increases the body&#146;s natural antioxidant protection by inducing the cells of the body to
produce naturally occurring protective antioxidant enzymes, a process which is thousands of times
more effective than traditional vitamin-mineral supplements. Free radical damage occurs when a
person is subjected to environmental stresses and generally increases with age. Data from a
peer-reviewed scientific study in men and women, sponsored by LifeVantage, show that after 30&nbsp;days
of taking Protandim<SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP>, the level of circulating toxins produced by free radicals decreased an
average of 40&nbsp;percent. With continued use, the decrease was maintained at 120&nbsp;days. For more
information, please visit the Protandim<SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP> product web site at <U>www.protandim.com</U> or contact Jan
Strode at (619)&nbsp;890-4040.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>About LifeVantage Corporation</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">LifeVantage Corporation is a publicly traded (OTCBB: LFVN), science based, natural products
company, dedicated to helping people reach their health and wellness goals through science-based
solutions to oxidative stress. Founded in 2003 and based in Colorado, LifeVantage develops
nutraceutical products, including Protandim, that leverage the company&#146;s expertise and that are
intended to deliver significant health benefits to consumers. For more information, visit
<U>www.protandim.com</U> or contact Jan Strode at (619)&nbsp;890-4040.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><I>This document contains forward-looking statements made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995. The Company uses the words &#147;anticipate,&#148;
&#147;believe,&#148; &#147;could,&#148; &#147;should,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;predict,&#148; &#147;project,&#148; &#147;plan,&#148;
&#147;target&#148; and similar terms and phrases, including references to assumptions, to identify
forward-looking statements. These forward-looking statements are based on the Company&#146;s current
expectations and beliefs concerning future events affecting the Company and involve known and
unknown risks and uncertainties that may cause the Company&#146;s actual results or outcomes to be
materially different from those anticipated and discussed herein. These risks and uncertainties
include, among others, the risk that government regulators and regulations could adversely affect
our business; future laws or regulations may hinder or prohibit the
production or sale of our existing product and any future products; unfavorable publicity could
materially hurt our business; and the Company&#146;s ability to protect our intellectual property rights
and the value of our product. These and other risk factors are discussed in greater detail in the
Company&#146;s Annual Report on </I><I>Form 10-KSB</I><I> under the caption &#147;Risk Factors&#148;, and in other documents
filed the Company from time to time with the Securities and Exchange Commission. The Company
cautions investors not to place undue reliance on the forward-looking statements contained in this
document. All forward-looking statements are based on information currently available to the
Company on the date hereof, and the Company undertakes no obligation to revise or update these
forward-looking statements to reflect events or circumstances after the date of this document,
except as required by law. In light of these risks and uncertainties, investors should keep in mind
that the results, events or developments disclosed in any forward-looking statement made in this
news release may not occur.</I>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"># # #
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>CONTACTS:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="50%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>LifeVantage Corporation</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Jan Strode, Investor Relations</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>Telephone: (619)&nbsp;890-4040</B></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Bradford Amman, CFO</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>Telephone: (720)&nbsp;488-1711</B></TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>c73415p7341501.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 c73415p7341501.jpg
M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$``("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("
M`@("`@,#`@(#`@("`P0#`P,#!`0$`@,$!`0$!`,$!`,!`@("`@("`@("`@,"
M`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`__$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$!
M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,`
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1
M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`$@`]P,!$0`"$0$#$0'_V@`,
M`P$``A$#$0`_`/W\H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`
M*`"@`H`*`"@`H`*`"@`H`*`"@`H`\R^)_P`-H/B-I,-H?&7Q$\$7NFQWTFGZ
MO\//&NN^$;M)KJ&-=^H6^EW<=IK<43P1/'#J$$ZH1((]@GE\RX2Y'\,6NS2?
M_#?(\_,,`L=24/K6)P<H*7+/#5ZE%IM+XE!J-1)I-*:=M;6YI7_.G_@G^?'G
MQ6U/QUXN^(GQ?^+/B8?#SQ'IFDZ'H%SX^\20:!=3217T]Q>Z[IL.H*FM(1!`
MJVEUYEO_`*PR1R%EV=%?E@HQA"*O?7E5_EV/B>#?KF85,7BL;F6+K?4ZD(PI
MO$553;?,VZD>>TUHDHR]W>Z=U;]8ZY#]&"@`H`*`"@`H`*`"@#\G_P!O#P]\
M4?A!#HWQ5^'?Q@^,VE>$M=\2MIGC?P];?$/Q+/8:'<:B[7EE>^'$GU!CHUE.
ML5[:BTC(@AD^R+"J*Y0==!QE[CA&\=M%^)^=<7T,PRQ4LPP.98ZGAJU1PKTE
MB:O+3<KRC*E>?[N,O>7+\,6HJ-D['Z9>`9-&F\$>$[CP[JFIZWH5UX?TJ\TC
M5]:U>_U[5M2T^\LX;FUO=1UG4[B:ZU"\FBE5Y)9Y68LQ'```YI74FFK-/9*R
M7RZ'WF"=+ZIAG0J3JT94X2A.<Y5)RC**:E*<VY2DT[MMWN=3/$L\,T#M*B31
M21,T$TMO,JR(49H9X'22"4`DK)&RLI`92"`1)T-73CJDTUHVGKV:LT^S6JZ'
MYS_#+P)XI\0?M5?$O2=-^,?QHU#X/?!X>&@=$U#XG>+M0@O_`!]J=E;:C-X=
MOM2N-3-SJNBV"+<2W-I<33;FEAMYR\197Z922I1?)%2E?:*6G>UM'M8^(P&"
MQ%7B#'4J>9XZ66Y9[-\DL57DI5Y1C+V3FYWG3BU)SC)O7EC)M-I_H[7,?<!0
M`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0!%/\`ZB;_`*Y2?^@&@3V?H?EI
M_P`$O?\`D`?'3_L?],_](M1KJQ.]/T?Z'Y_P!_!S7_K_``_])F?JA7*?H)CZ
M_<ZY9:3>7'AO2K'6M9A16LM+U'5I-#L[MO,7S(Y-4BTV_-J?*+E3]ED!8*K;
M0Q96K7LW9>7^6AE6E6A2E*A3C5JKX82G[.+UU]Y1GRZ?W7=]MSY%^%G[5?B[
MXI?%3Q/\*++X*R>']7\`7QMO'M_JWQ!TR6ST.*+43IT\FG)8:#*^N3,ZR/#'
M&8$D5,O+$&!K65*-.*ESZ/;3_@Z'S>7\0XG'9A6RZ&5>QJ8236(<L3&U-*?(
M^51I?O'>_*DTG;62O<]_^+WCCQ9\.?!^H>+_``OX%B\>Q:#9W^JZ]I8\3P>&
MK^VT;3;22\NKS33=:7=PZE.D44K&V9[=B$_=EW(0YPBG)1;Y;[:=?O5KGLYG
MB\3@<-/$X?"+%QH*4ZD?:JE*,(KFE*-X34FDFW'1]KO0^>?A5^U+\4?C-X37
MQKX`_9MO[_P\]]=Z=!>7_P`5?".D&YN[%E2[6&WO-/6;RXY'V>8\:*6!"D@$
MC65*%-\LJG*UTY7^C/$P'$&8YEA_K6"R)U*',XJ3QE&%W'=)3@GI>U[)7/5O
MA#\9O%OC_P`7^.O!'C;X2ZM\*M=\$V/AW4O(U+Q'IGB.'6;'Q'+J\5O=Z?=Z
M3:QV\ELKZ1.OF1RS`L61MCQ,M1."A&+C+F4FUM;:W^?D>CEF:8G%XG%X3%9=
M++JV$C2G:56-12C5<TG%PBHV]QZQ<EK;1IH\A^)?[6OC?X7_`!4\._";5/@+
M=:QKGC:Z2+P+=Z)\1M'-EXB@GOY+""21M0T*V_LBX$J`S0W3*(@X(D="':XT
M8RCS*=E'?W=OQ/-QW$>+R_,*.75,H]I5Q+2P[AB8VJIR<5\5)*#;W4FK;W:U
M.A\=?M`?'3X?>&]3\5ZQ^ROJUSHFB6DVH:K/I'Q7\(:I<6%C;1M-=7DUA9:=
M)<R6T,2O)(T,4NQ$9V`520HTZ;:BJNO1<K7YM(VQ6<YO@J-3$5>'I>QI1<IR
MCC*,^2*5VW&$'*W=I.V[LKL]A^*'@;3OCC\&?$7@^^A2WB\;^$TEL&E*R?V9
MJT]K#J>BW8D"#+6FJ):2%E"[A$PX#8J(/V4T_P"5_P##_>>GF&$AFV5UL+)*
M*Q5%.-_L3:4Z;_[=GROSMYGR=_P3K^)-_JOPV\0_!SQ07M_&'P7UZ[T.2RN6
MQ<IH-U>7?V6(JV&;[#JUOJMB>H2.*U7^(5KB(J,E..TU^/\`P5^I\[P3CISP
M-?*Z]XXG*ZCARO=4Y2E9/SA-3B^RY4?:GQ0\>:;\+_AYXQ\?ZL1]B\)Z#?ZL
M82<&ZN88BMA81XZS7=^]M;(!U>X4=ZQA%N48K37_`(<^IS#&0R[!8G&5-(8:
MG*=MKNWNQ]92:BO-GF?[+OP_U+P#\)-(E\2@MXZ\>7NH?$CQ]<R#$\OBGQE-
M_:MU;S$C<#96DEG8A22%^Q''6JJRO.T=(QTCZ(X.'\%/!9;3=?3%XN4L3B&U
M9^UK/F::[QCRP?FGW)_C!^T;X$^"_BOX8>$/$TI.I?$KQ$FD1&.XCA30-+DS
M:CQ'J896(T_^V)]/LP/DR)[B4-BT=6(4Y24G'117]+^O+N5F>=X3*L1@,-7=
MIXVHH:.WLX/3VDM/AYVETTYY7]QH^@:S/9/F+]HCX]^+OV?]"O/&;_"D^,_`
M]E)IUO<ZWI?C.TTR_P!.N-0D2V0ZIHMYH<C0V9O9(X%N+:XNLF:,R)$&XUIT
MU)\O-RR[6_6Z/`SK.,3DM*6)>7?6<'!Q3J1KJ$H.6BYJ;I-I.344XN6K5TKG
M??!#XV>"_CSX%L/''@RY(CDQ:ZSHER\?]J^&]8C16N=*U.*-B`Z[@\4R_NYX
MG26,X8A9G!TI<KZ;=#LRG-<+F^$ABL+*RVG3>DZ4UO"27WQ>TDTUV//?CU\>
M_&_P+A&NO\&[GQKX*GU'2-'MM>T'QI86NHPZIK,D5I96VI^'[W1?,M(9M3E6
MUCN(;FZ0M)#YGEM,JU4*<9:*7++M;];HX\WS?%Y0O:O+/K&$YH052%=1DISL
MHQE3=-N-Y/E33DF[7LY)&EX]^-GC3X?>%O`-W??"*\USXA?$#Q2/#6F?#;PU
MXNT^^NK9O[-U/5YKJ;Q#=:7;6;K:V&G%[DB-((O,)^T-&F]E&G&\K2M&*O>U
MNJ6U_/\`X!>+S7%8+#X)SRUSQN,J^RAAJ592<7R3J-NIR*.D8>]HHQ;NY\J;
M/)_B?^V#XT^#&A6?B3XE?LU^-O#FB7VHQZ1!?Q^./`>L0_VE-!/<Q6LBZ/J%
MQ)"9(;:X9'D1%;R6`.>#<:,9.T*B;]&K??8\['<2XK*Z4:V/R*MAJ4I*"E[>
MA-<S3E;]VY-:)N[26G<W/$7[2WQ?\->$+OQQ=_LH>.3X=L-(_MZ\N8_'_@*X
MN+?2!;"\EO9--TV\N[[RXK0F:55MF:-4<NH",0E2A>RJJ^UK/?YV7XFM7/<R
MH8>6*EP[7C0A#VCE]8H:0MS<SC!SJ6MJ_<O%:RLD[?6F@:Q;^(="T37[0%;3
M7-(TW6+52RN5M]3LX;V$%UX<B.=?F'!ZBLFK-KMI]Q]'0JQKT:-:.D:T(S7I
M.*DOP9XM\;?VC/`OP)U+X=:5XJD+WGQ"\4VNA01PW$<1T;2&=(=1\4Z@K*Q_
MLRSN;FQB=0%+FZ8JV(7Q=.E*2ERZ<J_'L>7FV=X3)IX*GB/BQE50232]G#:5
M67]V+<;K=W=OA9[^""`0000"".00>A!':LSV3Q;XL_'7PC\);CP_H-W;:OXI
M\>^,9S:^#?AYX4MHK_Q1X@F!97N%AEFB@TS28F5O.U"]F@@18Y""YB<+<*;E
M>UHQCNWHD>5F.;8;+71HRC/$8O$/EHX:BDZM1OK:Z48+6\Y-*R;5[.U$>,_C
MW!9'5;GX)>&G@">:WA[3OBQ;W'BM(P-S1JMUX/M=$GO`,CRAK*1EN!.0=U/E
MI[*HUY\NGYW_``(6*SE0]I+*:7+O[*.,3K>EG0C2<O+VMF_M&E\(?C?X8^,A
M\61>'])\4:%?>!]4M-!\3:5XLTD:+JFEZ[/;R7%SI<UG]HE)EM=FQY%8Q.S9
MB>1/F*E!T[:K7:QKEN:T,Q^L*C2JT)86485(58J$HS:;<6DWK%II]+[7/G_Q
MS^UQX[^'_P`7-"^#&I?`"ZU3Q5XN*3>#I=&^)&BMIVO:?-<WMO%>?:-1T*U&
MF%3871FBNMAB\HG+J49](T8N/,IVC'?3;\?R/%Q?$>,P68TLKGD_/B<19T>3
M%1Y:D6Y)2O*E%1^&5U)JUGTLWU/C+]H+XS?#_3H->\4_LS:A:>&AJNBZ;JFL
MV'Q5\):O_8\>M:O9:/%?76G6&GM<R6R7-]#N:-&50=TC1H&=4J<'I&IKT7*T
M=&(SG-,%!5<3D+HX>,HQE46+HSY.>2@FXP@Y?%)+:ROJTKL^O:Q/I2*?_43?
M]<I/_0#0)[/T/RT_X)>_\@#XZ?\`8_Z9_P"D6HUU8G>GZ/\`0_/^`/X.:_\`
M7^'_`*3,_5"N4_00H`_,3]E+_D]']L;_`+"DG_J2W%=57^#1^7Y'P7#W_)4<
M2?XI?^GF?>OQA_Y))\4?^R=^-?\`U&]2KGA\</5?F?79I_R+,Q_[!J__`*:D
M?FM^Q%\7O'/@G]GW3-(\/_`'XD?$.Q@U[Q1=Q^(?#-YX5@TJYFFO!))9Q1ZI
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MMO\`D?+\4594.(^'ZL*,Z\J=I*G3MSS:JWY8IM*[Z7:/==8_:/\`&>N^/?A1
M\.+WX&^/?A_H7Q%\5W6A^(M7^)&DZ))I.IZ)'X?UB[O/#EC%INI7\+7U\8HM
MQN'B(@AF"1R;V,<*E&,9R4TW!77*]G<]>KG>)J8O+L#+*J^"I8VLZ=26)A'D
ME35.;E3BHN4;STO=I\J=HN[:^W(((;:&&VMXHX+>WBC@@AB41Q0PQ((XHHT4
M`)&B*JA0````*P/JTE%*,5RQBDDEHDEHDEY'Y2_%#/[+_P"W-X/^*$7^@?#S
MX\P-HGBMQNCLK;5KN6RT_5YYB/E4PZI_PCVM.YY(N+S'5JZX+VE!QVE3V_3[
MU='YWF'_`!CW%N%QZ]S!9LN2KORQE)QC4;Z+EG[.LWN[R\SZH^/$?_"S?BC\
M(/@'!^^T=]1_X7!\3HEYC_X0[P3>1#PYI%XH.#!K/C&2TC*'&4TJ0]`:RI^Y
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M34Z.&H<T84.7GTG5BYSDM+U'"Z331^@/['OQB'QI^!/A/Q!>7(G\2Z'#_P`(
MEXM#,#,VMZ'##$+Z89SNU#3I+"_)(`W7CJ/N&N>M#V<VE[J>JZ?U9W1]GPSF
M?]J91AZLI7KT/W-;77GII)2?^.#C-^<FNAF_MNJK?LX^+XW57C?6O`221NH9
M'1_'GAQ71T8$,C*2"I&""0:>'_BKTE^3,^+?^1%BE;3GP^GKB*5_O/D'XN?#
M;QC^Q'\2F_:%^".GSZA\'M?N88/B;\/('D%EHT-U<9;RT4,+;2&FE9["]VDZ
M=<R?9Y,VER$;6,E6C[.6DX[/^NO?O^)\YF.`Q/"F._MC*8.6656EB<,KJ---
M[65[0;=Z<K7IR?+K&2C+Z1^/'Q*\(_%O]EZP\=^"-334M"UKQO\`"5T/RI=Z
M?=Q_$WPF+S2M3M@Q-GJ=K-F.6%CP0&4M&Z.^=*+IU>5JS2EY?9?YGM9SCL-F
M/#\,7A)\U&IB,'Y.,OK5'FA)?9E%Z-?-733?V+?>'-$U+6="\07VGQ7.L>&?
M[4_L&]D:42:8=:M4LM3>!%D$9DGM(Q"7=&949PI7>V[%-I-+1/='T\Z%&=6C
M6E!2JX?G]G+5<GM%RSLKVUCI=K:]MV?G[_P4^X_9\T+M_P`7,T#V_P"8+XDK
MHPNE1]++]4?&<?\`_(FH_P#85#_TW5/O?PS!#<^#O#]M<PQSV]QX9TF">"9%
MDAFAETNWCEAEC<%9(W1F5E8$$$@C!KG?Q/U9]CATI86A&24HRI033U33@DTU
MV:-`G1?"NA'BRT/P]X<THG"K'::=I&C:3:9(5$`2VL[6RM^`H"HD6`,"C5NV
M[?YE_NL-1^S1H8>'^&,(0CVV48Q7R2/R&^(&B?#W]I_X:?%_XN^)?'O@;3/'
MWB"<O\$/#^K^,=`L=4\,>!O`EQ?+I6D3V%QJ2RV&I>+97U6[NXI(U97OK`D@
M18'7'FHRA",7R+XFD[7EUTZ+\C\UQM+`Y]@<RS+$8S#TL;4?^PTJE:E&=*AA
MW)1@XN2<9XA\\I)K24H/R/M7]B3XQGXQ?`;PW=:A=>?XI\&@>"_$^]P;B6ZT
MB"$:9J4HZDWNCO93-(?O3"XP3M-8UH>SJ.RLGJOGO^)]5PIF?]I9/0E*5Z^%
M_<5==6X)<DG_`(H.+;ZRYNQ\X_LP:@_Q*_;8_:8\=^(<W6I>"TNO!WA6.X^?
M^Q='M_$%QH2+9(W%LQL=$(<H!EM3NB<F=R=*JY*%.*T4K-].E_U/#X?J?7N*
ML]Q=;X\)S4:2?V(*HZ2Y5T?+3L[?SR_F9^D_B?Q7X<\%://K_BK6++0=%M9(
M8[C4M0D,-I;O<.(XO.E"D1JSD#<V%'<@5S1B[VBM>Q]UB,30P=)UL15C0HQL
MG*6D5=V5WT/&OA[XS^`NH?$7Q7J7P^^)'A+Q#XK^)<>AWFJZ+X?UW3-5,LWA
M32[JQ35%M]-9WMY9-,>&.:2=@&^PPXPQ.ZY1J**4HN*A>UU;<\O`XK)I8[$S
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MI>,O^"AG[-OAFTE.A:_K?C[5MI%GH_A3PWK(>XN#Q%"U_K-G8VL2L^`6625A
MG(1CA3BL/4ZKD7]=%<^IQ'&F148M4*\\74Z0I4Y1U>RYJBA'ULV_)GL7P2\8
M_$+6O`6L?$[XT6^G^`;?7[ZX\0:'X5O9(;*/P'X%M[*WCT^/Q!J=VL+/JER(
MKG4KJ2Y\H1?;$C$<(C,4<3C&,E"&K6C?=^5OZ]=SU,JQ.,J8.KC\SY<)"M)U
M*=*5H+#X=17+[24K/FDU*<G+ELI+W8:Q7P1^RU\4/AY9?M@?M,ZQ>^+]#L-&
M\>:I=?\`"&ZQJ%XEAI/B,P^(I)"NEZE=^7;W#O'*CQ*),RJ=T0<"NBK"7L::
M47>-K^6A\?P_F&!AQ)GE66*ITZ6+G/V,Y2485+5F_=D[+5.\=?>6JN?H)^TC
MXY\+^`O@K\1+_P`3:M::8FJ>#_$NAZ/;RRJ+O6-:U71;ZTT_2],M0?,O+R:>
M9/DB5MJ!Y'VQHS+STHOGBHK9IOR5S[+/<7A\%E..E7J1IJI1JTX)M)SJ3A*,
M8175MOILKMV2;/E+_@FYX[\'CX):?\.I/$.F6WCFP\1^)[Z;PK=SBRUM[*ZG
M2\AO;.PNO+EOK4VVYVEMUE5-CARI4UIB(M3YK-1LE?8^>X'QF%_LN.!]O".+
MA5JR=%M*?+*TDXQ=N96W<;I6=[6/T0TS2-+T6&XM])T^TTV"ZO[_`%6YALX$
MMXY]2U6ZEOM2OI$C`#7-S>3S32R'EWD9CDFL+O[C[6G2IT5*-*$:2E*4VHI)
M<TVY2D[=92;;?5NY^2?[6/Q6^'UM^V%^SIK*>);&^TSX:WT+>.;S1_-UB+PV
MQ\1%Y8-0.F1SE;N"*)Y)K=`\L2CYT!(!ZZ4)*C-<K5[V6VZ/S?B+,<#'B7):
MBQ$94\!*/MW#WE2_>W:ERWU23<HJ\EU5VD?77C;]K[]E6"RTZ]O?&FF>-M3T
M;4[?6?#6@>&M*U37_$$GB"""XMK%]*LX+-5@U$QWMQ"CW$L"`7+AF`:L51JJ
M_N\BMKZ'TN*XEX=4:<GBH8JI2FITJ=.,IS]JDU'E5DHRM)I.3BM7=GTE\/M;
M\1>)?!GA_P`0>*O#I\):[K-B-2N_#+SFXN-$BO)99K#3[Z4HF=3BTY[072A5
M5+CSD4;5%922BVHO1=3W,%5KUL+1K8BC]6K5(\SI7NZ:DVXQDVE[RC;GT5I7
M70^;_P!N/X1?\+8^`/B=+"V\[Q+X&!\<>'3&F;AY-&@F;5[&(CYB;K1)+]51
M?O31V_!*C&M"?LZBZ)Z??M^)X?%N6_VADU?DC>O@_P!_3TU]Q/GC_P!O4W*R
MZR43F/V%]+\6>(_`5Y\<_B-<_P!H>,_B5::'HVFW;0B%K?P%X%LSH6@(B;B4
MEU"_35M3N'&!<27D<Y`W`!UW%-0AI&.OSEK^1APE2Q57"3S7'2<L5C5"G%M6
M<:&'C[."MT<YJ<Y/[3:EU,3]JWXV_#G5/%G@3]G/4_%UCINC^*/%FG2_&;5(
M[AQ8Z!X/TH_VI'X5UC4H`8],NO$&I6]G9S"1T,%JTK3[$N%)=*G)*4U'9/E5
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M6(H.47JJ-2%:%2$7V=XVA4^W&\)7DDW^WU<)^L'Y:?\`!37Q[X.O?AAHWPZT
M_P`0:=J/CBW\=Z1J]YX8TV=;[5M.TVUT761+=:G;6F]M-0F_L]@N/+:3[0I0
M,H)'5A8R4G+E:C;1_-;'Y[Q[C,++`4L#3KPEBXUXSE2C).<(JG4UFE\'QQM>
MS=[I-7/O+X,_$KP)\2/!.B7O@;Q1I/B&/3M%T2VU2"QN4-]I%VVGQ*+35M/;
M;<:;=;H9AY=Q'&28GVY"DUA.$J<G=<NKM_P#[#*L?@\=A*,\'B(5E3ITU)1?
MO0?*M)Q^*#T>C2V9\N_M=_&_P#_:'A']GJ[\7VNE1^//%&CV7Q:U2VF<Q^$?
MAY'-'>:EI^K7MNK+I-YKI2WL!YK*8K2YNII@D;HSZT:<M9J+]U/E7GW_`*ZG
M@<2YM@E+#Y++%1I+%5:<<9)/^#AKIRC)KX)5=(Z_#!R<K)J_T-HOP._9LUG2
MK'5=`^%'P<UC1[JW1]/U33O!WA#4K*[MX\Q++!J$-A*ETH,;*9!(Y+(V3D&L
MW4JK3GDFNEVOP/9I91D-2G"I1RW!5*37NSC0HRBUM=246GZW]3\U?A3\5_A;
M^S?^V/\`%#PUX>\2:9'\#?'AMXY=2TW?-X6\)>*!"NHVULMW:*]O%I]EJ-SJ
M^EF6,F*&.]A61E6U8ITSA.=&+::G'Y-KK_G_`,.?"Y=F.79%Q-F%"AB(1RG%
M63E%_NJ-6RG%75URPG*=*\=(J2NTHMGIEW!=?LM_M0Z]\>(+*[\1_L[?':P>
MXUOQ?X7MI=>LO"6I:O-;:M_:>H+I2S-_9IU:*:YCNHU:.2TUB81EYK8QO'QT
MU3^&I#H]-M+?UL]]#T'&7#^?ULWC%U<DS6+E.M27/&E*HU4YY<E].=.2:TE"
M;4>::Y7]N/\`M+_`>6PBN=,^)7AGQ/)>1$V6B>$[D^*O$>HLZ_):6GAK0H[K
M49;F0D)Y36RX+8?:,D8^RJ+[#BEWT7W['U3S[)^12IX^E7<OAIT7[6K)_P`J
MI4U*I=[6<5YV/GC]BKX1>/?`/B7X[>-O&/@C_A!M-^)WBFUU_P`(Z3=3Z0=7
MM-'?4O$M[]AU#3M,GE.C20PZE99M9"F&)&T&,XTK3C:$8N_)H[>B_/4\7A7+
M<9@J^;8O$X1X.GCZD:E&$N13C!SK2Y91@WR64X^Z[:]-#Y\_:-^+?PZM/VY/
M@3XH7Q387WA_X?Z9%IWC+5='$VL6?AZ]EU/Q(KVU[)ID4_[Z!;RV>X2+S&A6
M3YP&4J-*4)>PG'E:<MNG1?UYGBYYF6!I\6Y37^LQE1P48QK3A[ZIR<ZUT^2^
ML>9.25W%/770^O/&O[8'[-]I#IE]HVO6_P`4?&NEWTEQX&\'^#-.U#6/$U_X
MDU#3K[08H-,VV8ATZ6>QU>^M99[B1%2"[G.UV`1L51J*^CA'JWII?MZ_+NT?
M38CB7(OW4J->..Q5.3="C1C*=1U90E"T?=M%N$Y1=]7%M14I-1?U9X=GUJZ\
M/Z%=>([&UTSQ#<Z/ID^O:;8W#75EI^M364$FJ6-G=.H:YM8+YIXHY6`+I&K$
M`FLG:[MM?3TZ'T-!U94*,J\%3KRA!U(1=XQFXISC%]5&5TGU2N:,]I:W(07-
MM;W`C;?&)X8Y1&^,;D$BG8V"1D8/-+;;3\#1QB[7BG;:Z6@HM;95V+;P*@XV
MB*,*`?\`9"XH#EBM.5)+R1`-,TT2+*-/LA+&=R2"T@$B-U#*XCRI]P:+V\K$
M^SIIWY(IK9\J5OP+<D4<L;PRQI)%(I1XI$5XW4]5=&!#*1U!%&VVEBFE;EMI
MV>WW%9M.T]HUA:QLVB0@I$UM"8T(P050IA2"!T':C;R%R0M;DC;M96^XFEM[
M>;R_.@AE\EM\7FQ))Y3D%2T>]3L;:2,C!P2*-O+\!N,7:\4[;76WH-^R6@E2
M<6MN)X@PCF\F,2QA@58))MW("I(.",@XHVT6@N2*:?*DUL[),L4%%2.PL8F9
MXK*TC>1F=VCMX49W8EF=F5`68DDDGDDT$J$([04?1);[_>`T^P659ULK19T.
M4F%M")5/JL@3<I^AH\@Y()W4(IK9V2:+=!0QPFQED"^65(</C85888,&XVD$
M@@^M'H#M;7;_`#.6/B+P-X8M+?3CKGA/P]8V,*6UK8G4]'TFTL[>%0D<%O;>
M?%';PQH`JHBJJ@```4[2Z)G-[?!X:,:?MJ-"%-64>>$(Q2V25TDEV2T.3N_B
M]\#K`S?;?B;\++0RLS3B?QCX4B:1S]]IE;4`78]RP)-4H5.D)>6C.:69Y13O
MS9AA(=[UZ*^_WC&/[1W[.]E&MNOQE^%D$48V+!#XQ\/>4BG/RK'#>E57KP!B
MG[*I_)+[F9?V[D<%RK-,)%+HJ]*R^2D9Z?M&?LS^6UNGQ=^$ZP_=:$>)O#Z0
M\Y&-GGA2.O;%'LJO\DON9"SS($N59G@TET]K32^ZYJVWQZ_9YN7C-M\7/A,\
MD<2PQ-_PF7A:-XX5SLA0O?J4C&3A!@#/2CV=1?8DODS2.<Y(VN7,\'>*LOW]
M%:=E[RT\CI],^)?PEFW#1_B!\.Y3,P=QIOBKPTYE<C`=Q;7Y+OCC)R:GDFOL
MM?)G13Q^6_\`+G&X;O[M:E^DCL8+_1=9AV6M[I>JP,4?;!<VE]"2CK)&VV-W
M4E9%1E/9E!'(%*SCTY;?(ZE.E45HRA./DTUIJMK]34I&A6%G9K+),+2V6:4@
MRRB"(2R$`*#))MW.0H`Y)X&*-M-DB>2*;?*D^KLDQT-K:VS2-;VT%NTI!E:&
M&.)I"N=ID**"Y`)QG.,FC;RL-1C&_+%1OO9)?D-^Q6>Z5OLEMNF.Z9O(BW2L
M0`3*=F7.`!EL]*-O*PN2*O[J7?1?B2PPPV\:P011P0Q@A(846*-`220L:`*H
MR2>!W-`TE%*,4HI;)*R^Y%==/L$C,*6-FD39W1+;0K&<YSE`F#G)[=Z!>S@E
M90BEVLK?<6%AB2(0)%&D"IY:PJBK$L>-OEB,#:$V\;0,8XH&DDN5)**TMLDO
M0I66CZ1IDDDNG:5IVGRR_P"MDLK&VM)).<GS'@B4OSSR33N^Y,*5*FVZ=.--
M]>6*C^21HTBRI'86,!8PV5I"69F8QV\,99F)+,Q5!EB222>N:-O*Q*A"/PPC
M'T26XJ6-E%,+B.SM8YU!"SI;PI,H8%6`D5`P!4D'!Y!H!0A%W45%KJDD_O+5
M!04`%`!0`4`%`!0!Q_BSX@^!/`5HU]XU\8^&/"=HJ%Q+X@US3M(#J/\`GBM[
M<1M,Q/18U8GH`::C+[,7\D<V(QN#P<>;%8JEAET]I4C"]^R;3;\E=L^;-3_;
MA^"OGR6'@.W\?_%W4D)1;3X8^`]?UZ)INT8U*YMK.R8$_P`<<\BXYYK149:7
MM!=V[+\#PZG%667G#!QQ&85(:.&&H3D[]DY<B?K&YS\OQ^_:F\4G9\.OV2-5
MT:!@3'JOQ5\::/X;55/W7ET.%H[I>#DJL[-VQ3]G3CO4U71?YJ_Y&3S?/JS2
MP7#TZ<']O$U8TVO6E+V<ONDS,DT'_@H=XMW-<^-O@3\*[:3_`)=]#T?4_$NH
MP*W97U6RO8&D`_B$P&1QBG>A&UHR?K_P''\C/V/&5?FYL3@LOB]O9Q<I+U4Z
M=:-UY3U,]OV3_P!H_P`1JQ\;_MH_$!%E_P!=9^#-"3P[;\_>5);+6;8!>N/]
M''TH]K3C\-)*WI^J;_$A</9W55L7Q+7MVHPE2_&%:"_\D7H5!_P3H\%ZDV_Q
ME\:OCIXL=N9!=^+;:&.0GKN6XTZ[;!_ZZ?C1[=KX81C;U7Y-+\"%P5AI?[SF
MF-K^3G"W_D\)R_\`)C5M/^":W[,=M@W6G>-M59>K:AXQN]S?[WV&WMOT`H]O
M4\M/7]6:PX(R.'V:TO6JH_\`I$8'46G_``3W_90M,9^&]Q=$=[KQ=XN;/U$6
MMQC]*7MZBV:7_;L?\C>/!V01_P"82;]<17_2HC<B_82_90B&!\(=,/\`UTU[
MQ=(?_'M?-+VU1=;?)+]#9<)Y!'18#_RM7_\`EI,?V&/V4L`?\*=T9<#'&L>*
ME/U)&O<GWH]M46TK?)?Y#_U4R#_H7I6_Z>U__EI0G_8)_9/G!'_"I[2'W@\2
M^,82/IM\0<4>VJ+JE_V['_(A\(\/_P#0"X^E?$+_`-RG.7G_``3H_94N<^5X
M)UBP/8V7C#Q("O\`NBYU"8?F#3]O4\O_``%+\K&+X,R'[-"K#TQ%7\I2DCF[
MC_@FE^SV"7T?5?BAX>F'W)-*\8Q`QD]"OVO1YC_X]3]O-::6735?J<[X'R;>
ME/$T)='&=.__`)-29!#^P3JNA-N\"_M2_'GPJ4YB1]=.H1)C[H:&VNM/5U]B
M!1[9?\^X_P!>J8EPC4H.^%SW'4&MKS=ONISI)_<7XO@%^VCX6?/A']KFT\11
M)]RV\?\`@6TN5<#HLUR?[3F&>[*P/>CGHVUI<OI_DN4N.3\3X9WP_$*K16T:
MU%?BY*O+[K&C#K?_``4)\(974?!7P*^*MK%SYNA:[J?A/5)U'78=4>UM4=AV
M^SXR:5J&EG*/KI;Y)/\`,N-7C'"W]IA<%CHQV]G-TYOYSE2BK_X#3@_:O^(W
MAL*OQ5_90^,WAB*/Y;K5?!D&G_$?2(2/O3&327MG2#OP)#CIFCV4=>2HM-K^
M[^%V_P`"X\0XW#J/]H</XS#]).@EB(Q\W)*$4O23.\\+?MD_LY>*+F/3O^%C
M6'A36'<1MHOCVRU'P/J$,K8`BD_X22UM+<ODXQ'</SQFI=&HK>[?M;_+?\#L
MP_$V2UI.'UV.&J0:3A74J+BWLG*:4-?*3U/I/3]2T[5;2*^TF_LM2L9QN@O-
M/NH+RTF7KNBN+:1XY!SU5CUK.S6EK>6Q[=.I3G%2I3C.#V<6FODUH7:"PH`*
M`"@`H`*`"@`H`*`.4\2>./"GA`1+K^M6ME<S_P#'GID2S7^M7Y)P%T[0].BG
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MMONL:4.'LFPTN>.`IU*E[N=;FKSYOYKUG.S]+>1[S9V5EIMO'::?:6MA:0C;
M%:V=O%:V\2CM'#`BH@]@HK,]B$(4XJ%.*A&.T8I)+T2LD6J"@H`*`"@`H`*`
M"@`H`*`"@`H`*`"@`H`*`.:\1>#?"'BZW:T\5^%?#OB6U9"C6^OZ)INKP[&&
M"OEW]M*`,'L*:E*/PMQ]'8PKX7"XF/+B,/2KQ[5*<9K[I)GA$_[(OP:L[M]3
M\#67B?X2:PS%_P"T_A5XOU[P=\YY!DTBUNY-(G7/\$NG.I'RD%>*T56>SM)+
MI)+_`(<\>7#65QFZF$C6RVL_MX2M4HO_`,`4G3^3AMIL:-KX-_:&\&;5\._%
M3PY\3M,BX32/BIX:70]<$2G*I'XV\#1Q1O,1E?-N_#UR23EB:+TG]AP?>+T^
MY_YEQPF=X3^!F-+'TUM#%TO9U+?]?\/97\Y4)>9TEI\5]6TC$/Q(^&_BKP2R
MY\S6M+1/'G@\`<>:=9\,1R7VGPD]9-4TC3E4$%F`Y"Y%]B2?E\+^YZ?<S>.9
M5*6F.P%;"=YP_P!HH>O/23G%>=2E!+JSU+1M=T7Q!9)J.@ZMIVL6#\)=Z9>6
M][;[L9*&2WD94D&?F1B&4\$`U#3CHU;\#T:5:E6@IT*D:D.CA)27WKKY&K2-
M`H`*`"@`H`RM0TZ>_'D_VG>6-I@;X]-9;2ZE_O*U_P#-+"A];;R)!VDIK3H9
MSIN7N^TE3CVA[K_\"W7_`&[ROS*^C^&=`\/F9]'TFSL9[DYN[Q(O,U"];.[?
M?:C.7NKU\\[IYI#[T-OOZ=+?(FEAZ%"[I4HP<OBDE[S_`,4G[TOFV;M(V"@`
MH`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@#E[SP;X=NKYM
M5CT]--UEN6UG1W?2-4D/I<W5BT;7\?\`TRNA/&>Z&FI-*W3MT^[H<\L+0<W4
M5/V=7^>'N3^;C;F])77D;MG!<VT?E7%XU[MP(YI88HK@KSGSVMPD4C=.4AB]
;P2<TOE8VA&4%RN7-;9M)/YVLON2+=!04`?_9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
